Position in ALNY
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$20,585,076
-$4,046,160 QoQ
Shares Held
62,215
+0.4% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Swedbank AB holds $1,230,784,492 across 20 Biotechnology names. ALNY ranks #8 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
11,586,693 | $555,813,663 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
992,108 | $187,558,017 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
215,590 | $166,573,457 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
271,553 | $121,259,276 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
792,187 | $44,750,643 | |
| 6 | EXEL |
Exelixis, Inc.
|
841,778 | $36,103,858 | |
| 7 | INCY |
Incyte Corp
|
362,456 | $34,114,358 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
62,215 | $20,585,076 |
All Filings in ALNY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,585,076 | 62,215 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $24,631,236 | 61,942 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $28,991,568 | 63,578 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $20,972,478 | 64,315 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $13,067,234 | 55,532 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $14,777,086 | 53,729 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $5,015,277 | 20,639 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $3,084,498 | 20,639 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $42,232,510 | 220,639 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $39,075,166 | 220,639 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $63,428,943 | 333,942 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $66,895,261 | 333,942 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $101,394,085 | 426,653 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $83,278,569 | 416,060 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $64,059,070 | 439,212 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $71,579,151 | 438,356 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $74,032,692 | 436,565 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $82,415,187 | 436,498 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $58,571,194 | 345,512 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $48,049,639 | 340,319 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||